# FACT II Acquisition Corp (FACTU)

> Source: Nexqual · https://nexqual.com/FACTU · data as of 2026-10-14 20:00 UTC · cite as "Nexqual, FACT II Acquisition Corp (FACTU), nexqual.com/FACTU" · informational, not investment advice.

**Price:** USD 10.97 (+0.00% on the day) · last close of Oct 14, 2026; US market pre market, not a live price. Prev close 10.97 · day 10.97–10.97 · 52w 10.45–15 · market cap null · NGM

## Key facts
- Analysts: None.
- Total return with dividends: 1Y +3.5% vs S&P 500 +18.1%; 5Y +10.4% vs S&P 500 +85.1%.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2025 | TTM |
|---|---|---|
| Operating income | -$2.2M | -$2.9M |
| Net income | $5.0M | $3.8M |
| Cash + short-term investments | $545K | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 30, 2026)


## Analysts
Consensus None.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2024-11-25) |
|---|---|---|
| Total return | +3.5% | +10.4% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +3.5% | +5.4% |
| Volatility (annualized) | 21.4% | 10.2% |
| Max drawdown | -14.1% (Jun 2026→Jun 2026) | -9.7% (Jun 2026→Jun 2026) |

## Peers (Shell Companies)
VYLR (Vylor Inc.) USD 73.34 -4.68% · DMII (Drugs Made In America Acquisiti) USD 10.19 +0.00% · CCXI (Churchill Capital Corp XI) USD 11.35 +1.70% · EVAC (EQV Ventures Acquisition Corp. ) USD 10.3 -0.10% · BCSS (Bain Capital GSS Investment Cor) USD 10.22 -0.15% · CEPF (Cantor Equity Partners IV, Inc.) USD 10.26 -0.24%

## More
Full page: https://nexqual.com/FACTU · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt